20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3593 | Src Inhibitor 1 | Src Kinase Inhibitor 1,Src-l1 | Src |
Src Inhibitor 1 (Src Kinase Inhibitor 1) is a potent and selective dual site Src tyrosine kinase inhibitor. | |||
TP2289L | RR-src acetate | RR-src acetate(81156-93-6 Free base) | Others |
RR-src acetate is a synthetic peptide derived from the amino acid sequence surrounding the phosphorylation site in pp60src. | |||
T13000 | Src Inhibitor 3 | Others , Src | |
Src Inhibitor 3 is an effective inhibitor of c-terminal Src kinase (IC50 <3 nM in CSK HTRF, <4 nM in Caliper assay). Src Inhibitor 3 increases T cell proliferation induced by T cell receptor signaling. | |||
T11745 | KB SRC 4 | Src | |
KB SRC 4 is a selective and potent c-Src inhibitor with antitumour activity that inhibits the growth of cancer cells. | |||
TP2137L | Pp60 c-src (521-533) (phosphorylated) acetate | Others | |
pp60 c-src (521-533) (phosphorylated) acetate is a regulator of focal adhesion formation and cell spreading. pp60 c-src (521-533) (phosphorylated) acetate also regulates cell motility and is a key component in the signal... | |||
T39185 | Pp60 (v-SRC) Autophosphorylation Site, Phosphorylated | pp60 (v-SRC) Autophosphorylation Site, Phosphorylated | |
pp60 (v-SRC) Autophosphorylation Site, Phosphorylated is a phosphorylated peptide derived from an EGFR substrate. It serves as a valuable tool for quantifying phosphorylated substrates in screening EGFR Kinase inhibitors... | |||
T39149 | Src Optimal Peptide Substrate | ||
Src Optimal Peptide Substrate, a highly specific substrate of Src, serves as a reliable indicator of Src activity. It enables accurate assessment of Src kinase function. | |||
TP2289 | RR-src | Others | |
Tyrosine kinase substrate peptide | |||
T1811 | WH-4-023 | KIN112,KIN001-112,Dual LCK/SRC inhibitor | Src |
WH-4-023 (Dual LCK/SRC inhibitor) is a potent and orally active Lck/Src inhibitor. It also potently inhibits SIK. | |||
T13062 | T338C Src-IN-2 | Others | |
T338C Src-IN-2 is a potent mutant inhibitor of c-Src T338C kinase(IC50 of 317 nM). T338C Src-IN-2 also inhibits T338C/V323A and T338C/V323S(IC50 of 57 nM/19 nM,respectively). | |||
T13061 | T338C Src-IN-1 | Others | |
T338C Src-IN-1 is a potent mutant-Src T338C inhibitor(T338C,IC50=111 nM relative to WT c-Src (10-fold increase)). | |||
TP2137 | Pp60 c-src (521-533) (phosphorylated) | ||
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain; phosphorylated at Tyr527. Binds to pp60c-src and pp60v-src at the SH2 domain, suppressing their tyrosine kinase activity and transforming potenti... | |||
T76391 | P60c-src substrate II | ||
P60c-src substrate II is a potent pentapeptide substrate for the tyrosine kinase pp60c-src [1]. | |||
T81577 | P60v-src(137-157) | ||
P60v-src(137-157) is a synthetic peptide that serves as an inhibitor of the tyrosine kinase activity of p60 v-src, with an IC50 value of 7.5 μM [1] [2]. | |||
T81106 | SRC-1 (686-700) | ||
SRC-1 (686-700) is a bioactive peptide encompassing amino acids 686 to 700, which include the second LXXLL motif from NR box II of steroid receptor coactivator (SRC1). These coactivator proteins facilitate transcription ... | |||
T81578 | P60c-src substrate II, phosphorylated | ||
Phosphorylated p60c-src substrate II is a pentapeptide and a phosphorylated polypeptide form of p60c-src substrate II. Phosphorylation is a critical post-translational modification (post-translationmodification) vital fo... | |||
T83752 | Biotin-SRC-1 (676–700) TFA | Biotin-Steroid Receptor Coactivator 1 (676-700) | |
Biotin-SRC-1 (676–700), a biotinylated and truncated variant of steroid receptor coactivator 1 (SRC-1), finds application in affinity-based reporter assays such as time-resolved FRET (TR-FRET) and amplified luminescent p... | |||
T0152 | Bosutinib | SKI-606 | Bcr-Abl , Src , Autophagy |
Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases. | |||
T8499 | ECF506 | Src | |
eCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM) | |||
T17267 | XL228 | IGF-1R , Bcr-Abl , Src , Aurora Kinase | |
XL228 is an inhibitor of multi-targeted tyrosine kinase (IC50s: 5, 3.1, 1.6, 6.1, 2 nM for Bcr-Abl, Aurora A, IGF-1R, Src, and Lyn, respectively). |